Aug 23, 2019 06:50AM
Aug 15, 2019 06:45AM
Aug 8, 2019 07:28AM
Aug 8, 2019 06:50AM
Aug 2, 2019 06:45AM
Jun 28, 2019 07:03AM
Jun 28, 2019 07:00AM Hemispherx Biopharma CFO Adam Pascale Announces Retirement
Jun 17, 2019 08:32AM
Jun 17, 2019 08:30AM
Jun 12, 2019 03:34PM
Jun 12, 2019 03:31PM
May 31, 2019 10:25AM
May 31, 2019 10:16AM
May 16, 2019 08:30AM Hemispherx Reports 2019 First Quarter Financial Results
May 13, 2019 12:22PM
May 13, 2019 08:30AM
May 8, 2019 08:30AM
May 6, 2019 08:30AM
Apr 30, 2019 08:34AM
Apr 30, 2019 08:30AM
Apr 25, 2019 08:30AM Hemispherx Biopharma's CEO to Present at Planet MicroCap Showcase 2019
Apr 22, 2019 08:30AM
Apr 2, 2019 08:30AM
Mar 13, 2019 09:07AM
Mar 13, 2019 09:06AM
Mar 6, 2019 08:25AM
Feb 28, 2019 10:30AM
Feb 28, 2019 08:30AM Hemispherx Biopharma Announces Extension of Rights Offering Period to March 5, 2019
Feb 27, 2019 08:30AM
Feb 15, 2019 06:00AM
Feb 12, 2019 02:17PM
Feb 6, 2019 05:34PM
Jan 31, 2019 08:30AM
Jan 24, 2019 11:59AM
Jan 23, 2019 12:00AM Hemispherx Biopharma’s CEO to Present at the 15th Annual NobleConXV Conference
Jan 2, 2019 08:30AM
Dec 19, 2018 08:30AM
Dec 17, 2018 08:30AM
Oct 29, 2018 06:39PM
Oct 24, 2018 08:30AM
Oct 22, 2018 08:33AM
Oct 22, 2018 08:30AM Hemispherx Outlines Ampligen Combination Therapy Clinical Study Strategy for the Treatment of Multiple Cancers in Letter to Stockholders
Oct 10, 2018 08:35AM
Oct 10, 2018 08:30AM
Sep 18, 2018 08:30AM
Aug 28, 2018 08:30AM
Aug 24, 2018 08:30AM
Aug 15, 2018 08:38AM
Aug 13, 2018 08:30AM Hemispherx Updates Stockholders, Highlighting Ampligen’s Role in Enhancing Immunotherapeutic Therapies
Jul 9, 2018 08:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All